Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 07-2005 | 06-2005 | 04-2005 | 03-2005 | 01-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 931 | -6,325 | 449 | -2,980 | 1,541 |
| Depreciation Amortization | 348 | 231 | 121 | 114 | 712 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -762 |
| Accounts receivable | -1,805 | 67 | -2,057 | N/A | 325 |
| Accounts payable and accrued liabilities | 950 | 80 | -34 | -70 | -1,310 |
| Other Working Capital | 959 | 124 | -578 | -312 | -869 |
| Other Operating Activity | 863 | 1,958 | 2,091 | 1,197 | 840 |
| Operating Cash Flow | $2,246 | $-3,865 | $-8 | $-2,051 | $477 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -6,907 | N/A | -7,894 | N/A |
| PPE Investments | -199 | -110 | -28 | -69 | -534 |
| Sale Of Investment | N/A | 7,934 | N/A | 7,934 | N/A |
| Purchase Sale Intangibles | N/A | -71 | N/A | -43 | N/A |
| Other Investing Activity | 0 | -71 | 0 | -43 | 0 |
| Investing Cash Flow | $-199 | $846 | $-28 | $-72 | $-534 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 3,212 |
| Debt Repayment | -128 | N/A | -70 | N/A | -3,591 |
| Common Stock Issued | N/A | 8 | N/A | N/A | N/A |
| Financing Cash Flow | $-128 | $8 | $-70 | $N/A | $-379 |
| Beginning Cash Position | 840 | 8,813 | 840 | 8,812 | 1,276 |
| End Cash Position | 2,759 | 5,802 | 734 | 6,689 | 840 |
| Net Cash Flow | $1,919 | $-3,011 | $-106 | $-2,123 | $-436 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,246 | -3,865 | -8 | -2,051 | 477 |
| Capital Expenditure | -201 | -110 | -28 | -69 | -629 |
| Free Cash Flow | 2,045 | -3,975 | -36 | -2,120 | -152 |